Gian Lifecare Ltd vs Suraksha Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Gian Lifecare Ltd is ₹ 4.2 as of 23 Oct 15:30 . The P/E Ratio of Gian Lifecare Ltd changed from 9.8 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Suraksha Diagnostic Ltd changed from 42.2 on March 2025 to 36.9 on March 2026 . This represents a CAGR of -4.38% over 3 years The Market Cap of Gian Lifecare Ltd changed from ₹ 42.97 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Suraksha Diagnostic Ltd changed from ₹ 1342 crore on March 2025 to ₹ 1187 crore on March 2026 . This represents a CAGR of -4.00% over 3 years The revenue of Gian Lifecare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 88.73 crore as compare to the Mar '26 revenue of ₹ 82.2 crore. This represent the growth of 7.94% The ebitda of Gian Lifecare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 31.53 crore as compare to the Mar '26 ebitda of ₹ 25.15 crore. This represent the growth of 25.37% The net profit of Gian Lifecare Ltd changed from ₹ 0.09 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Suraksha Diagnostic Ltd changed from ₹ 7.67 crore to ₹ 12.85 crore over 9 quarters. This represents a CAGR of 25.78% The Dividend Payout of Gian Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Suraksha Diagnostic Ltd changed from 0.76 % on March 2026 to 0.76 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Gian Lifecare Ltd

Gian Life Care Limited was incorporated as a Public Limited Company and registered with the Registrar of Companies, Uttar Pradesh, Kanpur with the name & style 'Gian Life Care Limited' pursuant to a Certificate of Incorporation dated November 06, 2018.
Subsequently, Company acquired the entire business of M/s Gian Pathology & X-Ray, sole proprietorship concern of its Promoter Mr. Arun Kumar Gupta w.e.f.
March 01, 2019. Company is a fast growing professionally managed organization with an ultra-modem fully integrated, manufacturing facility dedicated to provide diagnostic services.
It established the organization in 2018.
Gian' is committed to Quality services that address the prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. The diagnostic center under the name of 'M/s.

About Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata.
Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India.
In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors.

FAQs for the comparison of Gian Lifecare Ltd and Suraksha Diagnostic Ltd

Which company has a larger market capitalization, Gian Lifecare Ltd or Suraksha Diagnostic Ltd?

Market cap of Gian Lifecare Ltd is 4 Cr while Market cap of Suraksha Diagnostic Ltd is 1,556 Cr

What are the key factors driving the stock performance of Gian Lifecare Ltd and Suraksha Diagnostic Ltd?

The stock performance of Gian Lifecare Ltd and Suraksha Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gian Lifecare Ltd and Suraksha Diagnostic Ltd?

As of October 25, 2026, the Gian Lifecare Ltd stock price is INR ₹4.2. On the other hand, Suraksha Diagnostic Ltd stock price is INR ₹298.9.

How do dividend payouts of Gian Lifecare Ltd and Suraksha Diagnostic Ltd compare?

To compare the dividend payouts of Gian Lifecare Ltd and Suraksha Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.